Status:
COMPLETED
DCI COVID-19 Surveillance Project
Lead Sponsor:
Temple University
Collaborating Sponsors:
Dialysis Clinic, Inc.
Conditions:
Covid19
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antib...
Eligibility Criteria
Inclusion
- Patients who receive in-center chronic dialysis (\>3 months) at DCI Henry Avenue
- Patients who are able to consent for study
Exclusion
- Patients receiving transient hemodialysis at DCI or receiving hemodialysis for Acute Renal Failure
- Patients who are unable to consent
- Patients who are receiving other forms of dialysis therapy (e.g. home hemodialysis, peritoneal dialysis)
- Patients whose life expectancy is \<12 months
- Patients who are planning to leave the dialysis center within 12 months
Key Trial Info
Start Date :
February 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04780698
Start Date
February 12 2021
End Date
October 13 2022
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dialysis Clinic, Inc.
Philadelphia, Pennsylvania, United States, 19129